Larimar Therapeutics, Inc. — Director's Dealing 2019

Jun 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2019-06-26

Reporting Person: McDonough Cameron Geoffrey (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-26	Stock Option (Right to Buy)	$1.25	A	27000	Acquired	2029-06-26	Common Stock (27000)	Direct

Footnotes

F1: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 26, 2020 or the date of the 2020 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company.